New article: Lenvatinib Beyond First-Line Therapy in Patients With Advanced Biliary Tract Carcinoma https://t.co/dsG9vSxkDf #livercancer #oncology https://t.co/1Zc0Ygh0yd
906 followers
38 followers
Lenvatinib Beyond First-Line Therapy in Patients With Advanced Biliary Tract Carcinoma https://t.co/6lE3qrjhPn
906 followers
New article: Lenvatinib Beyond First-Line Therapy in Patients With Advanced Biliary Tract Carcinoma https://t.co/hcA4XEHD9R #pancreaticcancer #oncology https://t.co/BTEmn7OtA1
6,544 followers
New research: Lenvatinib Beyond First-Line Therapy in Patients With Advanced Biliary Tract Carcinoma: Introduction Lenvatinib, a multiple receptor tyrosine kinase inhibitors that target vascular endothelial growth factor receptors and… https://t.co/UEB1h4